Delivery Order SPE2DB25D3008-SPE2DB25FRCDW
Award Date 5/27/25
Potential Completion Date 6/17/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,380.39 to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets on December 10, 2025, with completion scheduled for January 2, 2026. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-unit packaging) with a firm fixed price structure. The contract is non-competitive and competitively awarded with an ultimate completion date of July 16, 2025. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the point of delivery for this pharmaceutical product. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,380.39 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets in quantities of 30 units. The contract, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, operates under a firm fixed-price delivery order structure with no set-aside designation. This award represents a competitively awarded transaction reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52 with completion scheduled for September 23, 2025, represents a non-competitive award issued under an existing contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This contract, valued at $1,385.52, is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 14, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of August 12, 2025. This non-competitive, firm fixed-price delivery order was issued without a set-aside designation and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with a completion date of November 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on December 10, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,460.13, is scheduled for completion by January 2, 2026, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a ceiling value of $1,460.13. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of January 2, 2026, and was issued on December 10, 2025. The contract carries no set-aside designation and identifies Conshohocken, Pennsylvania as the place of performance, which aligns with...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in...